Medical Devices Reimbursement Market Worth $1169.8 Billion By 2027

The global medical devices reimbursement market size is expected to reach USD 1169.8 billion by 2027, expanding at a CAGR of 10.4%, according to a new report by Grand View Research, Inc. The rising number of regulatory reforms and increasing efforts of healthcare providers to reduce costs and improve the quality of medical equipment are anticipated to propel the market growth. Medical device reimbursement is defined as the payment, a third-party private or public insurer pays to a healthcare provider for the cost incurred while using healthcare equipment.

The major factors fueling market growth are growing dependence on remuneration, increasing prevalence of chronic diseases, and growing preventive care. Rising focus on early diagnostics and preventive care may in turn lead to higher activity within the diagnostic device industry, thus promoting more remuneration share from them. For instance, a fundamental paradigm shift towards incentivizing early diagnosis through remuneration is noticed across developed economies, such as screening for breast cancer.

With the increasing demand for healthcare equipment, the remuneration services are expected to provide various opportunities for healthcare industries to poach upon. Additionally, an increasing number of people pursuing insurance and consolidation of the healthcare system are the major factors fueling the market.

North America held the highest revenue share of about 50.0% in the market in 2019 and is expected to maintain its dominance over the forecast period. Increasing adoption of healthcare devices reimbursement and raising awareness with regards to cost implications are expected to drive the market in the region. In addition, rising demand for healthcare equipment and an increasing number of healthcare centers is expected to drive the market in this region. With increasing chronic diseases, the demand for healthcare equipment is also increasing. As per the National Health Council Report, around 157.0 million people will suffer from multiple chronic conditions until 2020. Due to these reasons, the market is expected to show significant growth over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/medical-devices-reimbursement-market

Further Key Findings From the Study Suggest:

The private player segment dominated the market with a share of 64.7% in 2019 due to the presence of a large number of private players
The hospitals segment dominated the market with a share of 49.6% over the forecast period due to recent technological developments and high patient footfall requiring the use of healthcare equipment
North America is expected to dominate the market over the forecast period owing to strong reimbursement framework
The market in Asia Pacific is projected to witness rapid growth during the forecast period owing to rising penetration of insurance services in rural and urban areas.

Dental Adhesives And Sealants Market Size Worth $6.1 Billion By 2027

The global dental adhesives and sealants market size is expected to reach USD 6.1 billion by 2027, expanding at a CAGR of 18.9%, according to a new report by Grand View Research, Inc. The high demand for dental restorations, an increase in the geriatric population and road accidents, and the wide product range are expected to propel market growth over the forecast period. In addition, technological advancements in dental materials are also expected to increase adoption, thereby contributing to market growth.

The introduction of advanced dental sealants by market players are anticipated to dominate the market strategies adopted for growth. For instance, 3M introduced ‘Clinpro’ sealant which changes its color from pink to off-white upon exposure to light. This color change technology not only improves the accuracy of sealant placement but also aids in determining the amount to be placed. The user-friendliness of such technologies is expected to increase the usage and demand for thin plastic coatings among dentists.

Furthermore, the increasing influence of social media coupled with globalization has led to the convergence of concepts related to beauty, especially those concerning facial features. This has led to a rise in demand for dental cosmetic procedures such as tooth whitening, tooth bonding, and dental veneers, which is anticipated to support market growth. Furthermore, the rapidly aging population in countries such as Japan, the U.K., Germany, and the U.S. are anticipated to increase the requirement of dentures and related products.

North America accounted for the highest market share in 2019 owing to favorable reimbursement framework, growing prevalence of oral diseases, and high demand for cosmetic dentistry in the country. In addition, the presence of major players in the region also contributed to market growth.

In Asia Pacific, the market is anticipated to witness the highest CAGR over the forecast. The growth of the market in the region is attributed to growing awareness regarding oral health, increasing the aging population, and rising cases of tooth decay due to changing lifestyles.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/dental-adhesives-sealants-market

Further key findings from the report suggest:

By product, the adhesives segment held the largest market share in 2019 owing to high product availability and demand for cosmetic dentistry
Restorative adhesives held the largest market share of 58.0% in terms of revenue in 2019 owing to their broad applications and the presence of a broad product portfolio in the market
The resin-based sealant segment accounted for the largest revenue share in 2019 due to the high adoption of these products among dentists
In Asia Pacific, the market is expected to witness the fastest growth rate over the forecast period owing to the growing geriatric population and increase in oral health awareness in the region.

Fluoroscopy Equipment Market Size Worth $4.74 Billion By 2025

The global fluoroscopy systems/equipment market size is expected to reach USD 4.74 billion by 2025, according to a new report by Grand View Research, Inc. The unprecedented growth is believed to be a consequence of rising patient preference for minimally invasive surgeries. These devices facilitate early diagnosis and reduce treatment duration in majority of surgical procedures.

The growing demand is also a consequence of improved cost-efficiency, safety, efficacy, rapid recovery, and reduced hospital stay. These factors anticipated to fuel the demand for fluoroscopy equipment over the forecast period. Other advantages include fewer incision wounds and postsurgical complications that lead to higher patient satisfaction.

The market is also driven by technological advancements such as incorporation of radiation dose monitoring tools for optimized radiation in fluoroscopy equipment. Other advancements include robotically controlled C-arms, integrated navigation tools, and image guidance software. These advancements have led to enhanced image guidance during interventional, ablation, and biopsy procedures as well as improved optimization of working procedures.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/fluoroscopy-market

Further Key Findings From the Report Suggest:

C-arms segment is predicted to witness exponential growth owing to high cost-efficiency and wide applicability in different fields such as traumatology, orthopedics, vascular surgery for intraoperative imaging, and others
Cardiovascular emerged as the largest application segment in 2016 as a consequence of high prevalence of cardiovascular diseases, raising the clinical urgency for adoption of fluoroscopy equipment
Hospitals held the largest share in end-use segment due to high patient volume, consistent readmissions, and easy availability of high-end equipment
North America accounted for the largest share, which can be attributed to the extensive R&D activities that are likely to provide platform for growth through consistent approvals of new product
The fluoroscopy equipment market in Asia Pacific is projected to witness substantial growth over the next decade, due to growing awareness pertaining to availability and benefits of these devices, further triggering significant penetration
GE Healthcare, Philips Healthcare, and Siemens Healthineers together accounted for a dominant share in the global fluoroscopy equipment market in 2016
The key companies are aggressively undertaking collaborative strategies, new and advanced product development activities, and mergers & acquisitions leading to significant growth
In May 2015, Philips Healthcare launched DuoDiagnost, an integrated radiography and fluoroscopy system. This equipment was launched to yield higher price-performance ratio in different applications and achieve a greater return on investment

Epigenetics Market Size Worth $22.05 Billion By 2025

The global epigenetics market size is expected to reach USD 22.05 billion by 2025, according to a new study by Grand View Research, Inc., progressing at a CAGR of 19.7% during the forecast period. The growing prevalence of cancer and other diseases worldwide with an epigenetic modification base is expected to drive the market during the forecast period.

Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is estimated to attract pharmaceutical companies to collaborate for the development of therapeutic drugs, which will work in favor of the market.

The presence of pipeline drugs and their expected commercialization is anticipated to boost the growth of the market. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer.

Technology advancements in the epigenetics industry are majorly focusing on the detection of methylation markers related to cancer development. For instance, Epi proLung BL Reflex Assay by Epigenomics helps in the diagnosis of lung cancer by determining methylation of SHOX2 biomarker gene.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/epigenetics-market

Further key findings from the study suggest:

On the basis of product, reagents held the largest share in the market in 2017. They are projected to amount to approximately USD 7.06 billion by 2025 owing to increasing R&D activities in the field of epigenetics
The kits segment is expected to post a CAGR of over 20.0% due to the need for rapid and accurate detection techniques
DNA methylation, on the basis of technology, held the leading revenue share in the market in 2017, accounting for just over 47.0%. The rapid adoption of advanced techniques such as methylation-sensitive PCR (MSP) to improve diagnostics efficiency is poised to bolster the growth of the segment
North America commanded the leading position in the global arena with a share of 40.0% in 2017. The growth of the regional market can be attributed to the increasing prevalence of cancer and growing collaborations between large pharmaceutical firms for the development of improved therapeutics
Asia Pacific is estimated to register a noteworthy CAGR of 22.1% during the forecast period owing to the presence of a large target population coupled with high unmet clinical needs
Some of the major players of epigenetics market are Illumina; Abcam; Diagenode; Thermo Fisher Scientific; Merck; Zymo research; Qiagen; CellCentric Ltd; Chroma Therapeutics Ltd; Eisai Co. Ltd; Novartis International AG; Oncolys Biopharma Inc.; Syndax Pharmaceuticals, Inc.; Valirx Plc; and Sigma-Aldrich Corporation
Extensive R&D initiatives for the development of novel drugs and the presence of strong product pipeline are expected to further boost market growth over the forecast period.

Smart Pills Market Size Worth $3.0 Billion By 2025

The global smart pills market is expected to reach USD 3.0 billion by 2025 at a CAGR of 15.5% during the forecast period, according to a new report by Grand View Research, Inc. An increase in prevalence of diseases such as colorectal cancer and gastrointestinal disorders, expansion in the geographical reach of major players, rising cancer screening awareness programs, and expeditious FDA approvals are prime factors that are expected to drive the market growth over the forecast period.

Smart pills have transformed the landscape of small bowel, colon, and gastrointestinal endoscopy by providing a non-invasive and accurate method for visualizing distal duodenum, jejunum, small bowel, colon, gastrointestinal, and ileum. Smart pills are mostly used for screening and treatment of diseases such as colorectal cancer, gastroparesis, gastric ulcers, and gastroesophageal disorders.

Consumers of smart pills mostly include geriatric population, immobile patients, and patients with paralysis. Considering the steady rise in geriatric population around the globe, the demand for advanced medical devices will also increase as they offer a degree of convenience to patients. Established players in this market are enhancing their portfolio by upgrading existing devices. On the other hand, new players are focused on capturing emerging economies with breakthrough products that are both advanced and affordable.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/smart-pills-market

Further key findings from the report suggest:

Capsule endoscopy is the largest application segment owing to factors such as growth in cancer screening awareness programs, increase in the incidence of Crohn’s disease and bowel cancer, and an increase in demand for minimally invasive procedures
North America is the dominant region with the largest revenue share. The wide availability of products, favorable reimbursement policies, increase in government investments in healthcare, and an overall rise in healthcare expenditure support market growth
Asia Pacific is expected to witness the fastest growth over the forecast period. Factors, such as an increase in disposable income, mandatory healthcare insurance, and rise in healthcare expenditure are expected to drive the market
Commercially available smart pills include PillCam Capsule, ABILIFY MYCITE, CapsoCam, and Olympus Endocapsule
Key players in the smart pills market include Medtronic, Olympus Corporation, Proteus Digital Health, MediSafe, and CapsoVision

Video Analytics Market Size Worth $9.4 Billion By 2025

The global video analytics market size is expected to reach USD 9.4 billion by 2025, according to a new study by Grand View Research, Inc., registering a 22.8% CAGR over the forecast period. Increasing demand for intelligent security surveillance systems, which can be used for estimating key trends and deriving patterns, is the key factor driving the market growth. In addition, increasing concerns over public safety and the use of video analytics in criminal investigations are positively impacting demand for video analytics solutions.

Apart from surveillance, video analytics solutions have also found increasing applications in the retail sector for estimating average footfall, gender bifurcation, display effectiveness, and attractiveness of shelf space. Furthermore, superstores and mega marts have started implementing these systems to gain insight into consumer behavior.

The use of advanced algorithm technology in video analytics enables the examination of captured videos frame by frame, irrespective of light exposure, thereby making video analytics a reliable and efficient choice for ensuring security. Furthermore, industries such as transportation, retail, and healthcare are witnessing a significant increase in the adoption of video analytics, owing to rising application of intrusion detection, license plate recognition, crowd management, and congestion detection in these industries.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/video-analytics-market

Further key findings from the study suggest:

Facial recognition is expected to emerge as the fastest-growing application segment with a CAGR of 25.9% from 2017 to 2025. This can be attributed to the widening scope of facial recognition solutions for surveillance purposes at malls, events, airports, and public transport, among others
By type, the services segment is projected to register the highest CAGR of 24.0% for the next eight years. This can be attributed to increasing demand for and installation of video analytics solutions, which are, in turn, propelling demand for related managed and professional services
The cloud segment is anticipated to emerge as the most preferred deployment option for video analytics solutions as it offers flexibility and convenience, allows remote access, and provides easy maintenance
North America accounted for the largest share in 2016 and is driven by the presence of prominent market players who consistently work on developing new and innovative technologies in video analytics
The retail end-use segment is anticipated to register the highest CAGR of 25.6% over the forecast period. This may be attributed to the use of video analytics in applications such as people counting, display and promotion effectiveness, product placement and store layout, and customer preference pattern analysis
Asia Pacific is expected to experience the highest growth from 2017 to 2025, driven by emerging economies such as India and China. These nations are expected to augment their expenditure on intelligent and security surveillance systems
Key industry participants include Cisco Systems, Inc.; Axis Communications AB; Bosch Security Systems GmbH; Agent Video Intelligence Ltd.; Honeywell International Inc.; IBM Corporation; AllGoVision Technologies Pvt. Ltd.; Genetec Inc.; Aventura Inc.; and i2v System Pvt. Ltd.

Soft Tissue Repair Market Worth $10.73 Billion By 2025

The global soft tissue repair market size is expected to reach USD 10.73 billion by 2025, expanding at a CAGR of 7.3%, according to a new report by Grand View Research, Inc. A growing number of trauma patients and orthopedic surgeries is one of the key factors expected to drive revenue growth in the coming few years.

Soft tissue comprises of muscles, ligaments, tendons, fibrous tissue, skin, synovial membranes, nerves, and others which protect organs, enable movement and support bones in the body. Injury to the soft tissues can cause severe pain and also may stop the movement of the bones, which if left untreated can lead to chronic pain. Over the long-term, injuries hamper the everyday life of the patients as it becomes difficult to work, socialize, or even move. Most of the injuries are caused because of sprain, the trauma of strain on the muscles. Soft tissue repair surgery comprises of procedures wherein devices like grafts, sutures, anchors, and other devices are used to remodel, reshape, or fix the damaged parts to restore its functionality. With the growing number of related injuries, the products used in repair surgeries are expected to witness exponential demand over the forecast period.

Factors influencing soft tissue repair market growth are the growing number of patients suffering from sports-related injuries. Sprains, contusions, strains, tendinitis, and bursitis are some common injuries, that are suffered by athletes. Growing awareness about the impact of these injuries on athletes’ performance and awareness regarding available treatment options for soft tissue repair are expected to promote revenue growth of the market. The ageing population is another significant factor promoting revenue growth. Old people are more susceptible to fractures and trauma associated injury and often require joint replacement and reconstruction surgeries. According to a United Nations report in 2015, the population of people aged 60 years and above is projected to grow by 56% and is expected to reach 1.4 billion by 2030. This in turn is expected to bolster the patient pool for joint replacement and soft tissue repair surgeries and in turn propel revenue growth of the market over the forecast period.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/soft-tissue-repair-market

Further Key Findings From the Report Suggest:

The global soft tissue repair market size was estimated at USD 5.73 billion in 2016 and is expected to grow at a CAGR of 7.3% from 2017 to 2025
Fixation products emerged as the largest product type segment in 2016 and is estimated to generate revenue of over USD 6.15 billion by 2025
Orthopedic surgery segment was estimated at USD 1.47 billion in 2016 and is anticipated to witness the fastest growth over the forecast period
The Asia Pacific region is projected to witness substantial growth over the next decade owing to various developments across major economies in the region. This regional market is expected to grow at a CAGR of 7.7% from 2017 to 2025
Some of the key players including Stryker Corporation; Arthrex, Inc.; C.R.Bard, Inc., Integra LifeScience Corporation, Smith & Nephew plc. and Depuy Synthes